GLP-1 RECEPTOR AGONISTS HAVING IMPROVED PHARMACOLOGICAL AND DRUG DELIVERY PROPERTIES

Disclosed are polypeptides, compositions, and methods useful for activating a glucagon-like peptide- 1 (GLP-1) receptor and treating or preventing diseases or disorders at least partially mediated by glucagon-like peptide 1 (GLP-1). L'invention concerne des polypeptides, des compositions et des...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GRIBKOFF, Valentin, DILLER, David, SWANSON, Jon, SHRIER, Allison, PENTELUTE, Bradley, SAWYER, Jonathon, GUNASEKERA, Dinara, SAWYER, Tomi, AUDIE, Joseph, SANTIAGO, Solimar
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed are polypeptides, compositions, and methods useful for activating a glucagon-like peptide- 1 (GLP-1) receptor and treating or preventing diseases or disorders at least partially mediated by glucagon-like peptide 1 (GLP-1). L'invention concerne des polypeptides, des compositions et des méthodes utiles pour activer un récepteur de peptide-1 de type glucagon (GLP-1) et traiter ou prévenir des maladies ou des troubles au moins partiellement médiés par le peptide 1 de type glucagon (GLP-1).